4D Biomaterials is delighted to announce the world’s first public appearance of the 4Degra™ product range at the UK’s foremost Med-Tech trade

4D Biomaterials® has just completed a £1.6m ($2.2m) seed investment round led by DSW Ventures and backed by the MEIF Proof of

4D Biomaterials – so what’s new? An interview with Phil Smith is featured on the 3D Medtech Printing Conference website, read the

Are you looking to invest in disruptive new MedTech technology with the potential to become a substantial medical device/materials business? Building on